Letrozole
Composition
Contains Letrozole, a non-steroidal aromatase inhibitor.
Indications
Used for hormone receptor-positive breast cancer in postmenopausal women and for ovulation induction in infertility.
Side effects
Hot flashes, fatigue, joint pain, dizziness, bone thinning.
Precautions
Monitor bone mineral density; use with caution in patients with liver impairment or osteoporosis risk.
Contraindications
Pregnancy, premenopausal women , hypersensitivity to letrozole.
Dosage and administration
Breast cancer: 2.5 mg orally once daily; Ovulation induction: 2.5–7.5 mg daily for 5 days, starting on day 3–5 of the cycle.
Countries
Mexico, Brazil
Available Forms
Oral tablets